Evaluation of ERBB2 mRNA Expression in HER2-Equivocal (2+) Immunohistochemistry Cases

Carretero-Barrio, I; Caniego-Casas, T; Rosas, M; Sánchez, MC; Martínez-Jáñez, N; Chiva, M; Sarrió, D; Moreno-Bueno, G; Palacios, J; Pérez-Mies, B

Palacios, J; Pérez-Mies, B (通讯作者)，Hosp Univ Ramon & Cajal, Serv Anat Patol, Inst Ramon & Cajal Invest Sanitaria IRYCIS, Madrid 28034, Spain.;Palacios, J; Pérez-Mies, B (通讯作者)，Univ Alcala, Fac Med, Alcala De Henares 28801, Spain.;Palacios, J; Pérez-Mies, B (通讯作者)，Ctr Invest Biomed Red Canc CIBERONC, Madrid 28029, Spain.;Palacios, J; Pérez-Mies, B (通讯作者)，Hosp Univ Ramon & Cajal, Unidad Patol Mamaria, Madrid 28034, Spain.

CANCERS, 2023; 15 (6):

Abstract

Simple Summary HER2-equivocal cases represent around 15% of breast carcinomas, and 20-40% of them are HER2-amplified. The distinction between HER2-amp......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索